SCHEMBL10815175

SCHEMBL10815175

CCCCCCCCCCOC(=O)OCC(COC(=O)OCCCCCCCCCC)OCn1cnc2c(SC)nc(N(C)C)nc21

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDE3A Q14432 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ CYP3A4 P08684 7/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ VCP P55072 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ CYP2D6 P10635 6/20 0.31
▸ FGFR1 P11362 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ HK1 P19367 1/20 0.30
▸ HKDC1 Q2TB90 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10813165 0.96 PDE3A (0.41) PDE3ACYP1A2TSHRCYP3A4ALDH1A1
SCHEMBL9584672 0.89 ALDH1A1 (0.38) PDE3ACYP1A2TSHRALDH1A1LMNA
SCHEMBL10814397 0.88 CYP2C19 (0.43) PDE3ACYP1A2TSHRCYP3A4ALDH1A1
SCHEMBL10816341 0.85 CYP1A2 (0.51) PDE3ACYP1A2TSHRCYP3A4ALDH1A1
SCHEMBL10846484 0.84 PDE3A (0.46) PDE3ACYP1A2TSHRCYP3A4ALDH1A1
SCHEMBL10817760 0.81 CYP1A2 (0.48) PDE3ACYP1A2TSHRCYP3A4ALDH1A1
SCHEMBL10816715 0.79 CYP2D6 (0.45) CYP1A2CYP3A4CYP2D6FGFR1
SCHEMBL10815169 0.79 ALDH1A1 (0.31) CYP1A2TSHRALDH1A1
SCHEMBL10816124 0.79 PDE3A (0.36) PDE3ACYP3A4ALDH1A1MEN1LMNA
SCHEMBL9584601 0.76 CYP2C19 (0.43) PDE3ACYP1A2TSHRCYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0105135-B1 SUBSTITUTED 9-(1-0- OR 3-0-MONOSUBSTITUTED OR 1,3-DI-0-SUBSTITUTED 1,3 DIHYDROXY-2-PROPOXYMETHYL) PURINES AS ANTIVIRAL AGENTS SYNTEX (U.S.A.) INC. (US) 1987-03-18 — — EP disclosed
US-4609661-A HERPES VIRUS SYNTEX (U.S.A.) INC. (US) 1986-09-02 — — US disclosed
US-4556659-A Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1985-12-03 — — US disclosed
EP-0105135-A1 Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1984-04-11 — — EP disclosed
Send feedback